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tributions because one is mandatory. Clearly, the legal measure of
the cancer plan for a given department means that you belong to aDr Ara Vaporciyan (Houston, Tex). Dr Falcoz and his col-
leagues have leveraged a new modern multi-institutional databaseCOMMEN
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848 The Journal of Thoracic and Cardiovascular Surgto examine the impact of the National Cancer Plan on outcomes—
specifically mortality—associated with the treatment of lung
cancer.
I actually sent Dr Falcoz my questions ahead of time and he
actually already answered 2 out of the 3, so in the interest of letting
the crowd have an opportunity to ask a question, I’m going to go
right to the third question.
I suspect that it is hard, as you identified, to dissect the impact of
a new database and the Hawthorne effect from the impact of a new
National Cancer Plan. However, considering the health care envi-
ronment in the United States, I would imagine that many of us in
this audience are very interested in any evidence that demonstrates
the true value of a national health care plan or any sort of nation-
alization of care. Therefore, this question really focuses on what
you are going to do next. As the new National Cancer Plan in
France gains traction, how are you going to truly examine the
impact of that plan on the delivery of care?
Dr Falcoz. Thank you for your final question, Dr Vaporciyan.
It might be a little bit difficult to answer, because, as you said, it
is a challenge to highlight the individual contribution of the data-
base from the National Cancer Plan, especially as the participation
in our database is a mandatory requirement as one of the measures
of the cancer plan. So it is difficult to dissect between the two con-
database. To conclude, I don’t think it will be possible to clearly
give you an answer of who does what. The effects are mixed.TARYEditorial commentBenjamin D. Kozower, MD, MPHThe volume–outcome relationship has been used as a proxy
measure for quality for more than 3 decades since first pro-
posed by Luft and colleagues1 in 1979. In this issue of the
Journal of Thoracic and Cardiovascular Surgery, Falcoz
and colleagues2 report the results of lung cancer resectionin France captured in the Epithor database. From 2005 to
2010, the database captured the data for almost 20,000
patients undergoing anatomic lung resection for lung
cancer. The most striking result of their report was the
decrease in 30-day mortality from 10% in 2005 to 3.8%
in 2010.
The authors used sophisticated hierarchical logistic
regression models to evaluate the relationship between
procedure volume (both surgeon and hospital) and 30-day
mortality. Rather than categorizing the procedure volume
into arbitrary groups such as quartiles or quintiles, the
authors appropriately modeled volume as a continuous
variable using a polynomial function. The results have
demonstrated that surgeon volume, but not hospital volume,
was associated with 30-day mortality, with a P value<.05.
Although this is statistically significant, it is unclear howery c September 2014
